More specifically, the dysregulation of the lncRNA MIR31HG has been described in immune-altered environments such as cancer, modifying the cell survival by downregulating the expression of components of the Epidermal Growth Factor Receptor [50]. This evidence concerns the gene EGFR and cancer.